New Hampshire Cannabis Sales

Among small-tier markets, New Hampshire stands out for combining a nearly 20% annual sales decline with rising prices, a pattern more typical of supply-constrained medical programs than competitive recreational ones. The state's seven dispensaries have held steady for over a year, offering no new retail access to offset attrition, while neighboring New England states with adult-use programs and hundreds of dispensaries likely siphon considerable consumer spending across state lines.

24-Month Trend

State	Sales	YoY
Iowa	$1-2.5M	2.6%
Kentucky	$.5M-1M	N/A
New Hampshire	$.5M-1M	19.8%
Texas	$.5M-1M	105.3%
Nunavut	$250-500K	57.9%

Benchmarking

Market ComparisonApr 2026

Among small-tier markets, New Hampshire stands out for combining a nearly 20% annual sales decline with rising prices, a pattern more typical of supply-constrained medical programs than competitive recreational ones. The state's seven dispensaries have held steady for over a year, offering no new retail access to offset attrition, while neighboring New England states with adult-use programs and hundreds of dispensaries likely siphon considerable consumer spending across state lines.

24-Month Trend

State	Sales	YoY
Iowa	$1-2.5M	-2.6%
Kentucky	$.5M-1M	N/A
New Hampshire	$.5M-1M	-19.8%
Texas	$.5M-1M	+105.3%
Nunavut	$250-500K	-57.9%

Top performing dispensaries in New Hampshire.

Store	City	Est. Sales
#1 Prime Alternative Treatment Center	Merrimack	$250-500K
#2 Prime ATC - Chichester	Chichester	<$250K
#3 Sanctuary ATC - Conway	Conway	<$250K
#4 Sanctuary ATC - Plymouth	Plymouth	<$250K
#5 Temescal Wellness - Keene	Keene	<$250K

Vapes suffered the sharpest decline of any major category, falling nearly 31% year over year despite holding a quarter of market share. Edibles remain the top category at roughly 37% of sales but dropped more than 20%, while pre-rolls shed about a quarter of their volume. Concentrates proved the most resilient segment, dipping just 2.6% and holding around 11% of the mix. GraniteLeaf Cannabis continues to anchor the product landscape in a market where the narrow dispensary count limits brand competition and category experimentation.

Category	Sales	Avg Price	YoY
#1Edibles	<$250K	$30.59	20.5%
#2Vapes	<$250K	$31.26	30.7%
#3Pre-Rolls	<$250K	$11.89	25.5%
#4Concentrates	<$250K	$40.77	2.6%
#5Oral	<$250K	$48.43	20.5%
#6Flower	<$250K	$62.05	36.9%
#7Topicals	<$250K	$32.97	4.8%
#8Accessories	<$250K	$6.97	48.3%